Study of Single and Multiple Ascending Doses of KR23343 in Healthy Adult Participants

NCT07409922 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

92

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: KR23343
DRUG: Matching Placebo

Sponsor

Jiangxi Kvvit Pharmaceutical Co., Ltd.